MyMD Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
24 Aug 23 | BuyUS$166,500 | Paul Rivard | Individual | 5,000 | US$33.30 | |
17 Aug 23 | BuyUS$28,080 | Paul Rivard | Individual | 833.33 | US$33.70 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,459 | 0.16% |
Institutions | 207,574 | 9.62% |
Individual Insiders | 219,358 | 10.2% |
General Public | 1,727,241 | 80.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
124,815 | US$405.6k | 0% | no data | |||
103,616 | US$336.8k | 0% | no data | |||
68,295 | US$222.0k | 0% | no data | |||
48,609 | US$158.0k | 0% | no data | |||
15,000 | US$48.8k | 12.5% | no data | |||
9,707 | US$31.5k | 0% | no data | |||
6,869 | US$22.3k | -0.52% | no data | |||
6,248 | US$20.3k | 44.3% | no data | |||
6,247 | US$20.3k | 501% | 1.81% | |||
5,718 | US$18.6k | 0% | no data | |||
5,000 | US$16.3k | 69% | no data | |||
4,008 | US$13.0k | 0% | no data | |||
3,459 | US$11.2k | 0% | no data | |||
2,266 | US$7.4k | 70% | no data | |||
2,070 | US$6.7k | -42.8% | no data | |||
2,010 | US$6.5k | -55.5% | no data | |||
1,994 | US$6.5k | 0% | no data | |||
1,928 | US$6.3k | 46.3% | no data | |||
1,923 | US$6.3k | 0% | no data | |||
1,637 | US$5.3k | 0% | 100.0% | |||
1,286 | US$4.2k | 0% | no data | |||
999 | US$3.2k | 0% | no data | |||
999 | US$3.2k | 0% | no data | |||
933 | US$3.0k | 100% | no data | |||
837 | US$2.7k | 0% | no data |